NCT01610804已完成不适用
Choroidal Thickness Measurements During CSCR Treatment Applying EDI-OCT Technology
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 18
- 试验地点
- 1
研究概览
简要总结
The purpose of this study is to determine changes in choroidal thickness in patients with Central Serous Chorioretinopathy (CSCR) during the first 3 months after initial diagnosis via Enhanced-Depth-Imaging-Spectral-Domain-Optical-Coherence-Tomography (EDI-OCT).
Study hypothesis: Since exudative changes in the choroid seem to constitute the primary pathology of CSCR, changes in choroidal thickness compared to healthy eyes should be present and be visible using EDI-OCT.
研究设计
- 研究类型
- Observational
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 80 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •Patients with initial diagnosis of CSCR and no treatment so far
排除标准
- •Therapy (drugs/laser) due to CSCR
研究者
Caroline Brandl
MD
University Hospital Regensburg
研究点 (1)
Loading locations...
相似试验
已完成
不适用
Eplerenone Versus PDT: Comparative Study by OCTACentral Serous ChorioretinopathyNCT05104138Federico II University30
招募中
不适用
Central Serous Chorioretinopathy and Micropulse Laser TreatmentCentral Serous ChorioretinopathyNCT06346405Fondazione Policlinico Universitario Agostino Gemelli IRCCS36
已完成
不适用
Choroidal thickness in patients with central serous chorioretinopathy (CSC) and myopia10047060Central Serous ChorioretinopathyNL-OMON45973Oogziekenhuis Rotterdam30
已完成
不适用
"Cataract Surgery in Eyes With Epiretinal Membrane"Pseudophakic Cystoid Macular EdemaIrvine-Gass SyndromeCataractEpiretinal MembraneNCT03404323St John of God Hospital, Vienna30
已完成
不适用
Subfoveal Choroidal Thickness and Visual Acuity After Intravitreal Injection of Ranibizumab in Diabetic RetinopathySubfoveal Choroidal ThicknessIntravitrealRanibizumabVisual AcuityDiabetic RetinopathyNCT06173245Egyptian Biomedical Research Network50